课题基金 / 基金详情

Delivery of Polyphenols in Gum for Treatment of Gingivitis

Delivery of Polyphenols in Gum for Treatment of Gingivitis
在牙龈中输送多酚以治疗牙龈炎
批准号:
8312757
负责人:
CRAIG S MILLER
金额:
$31.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-23 至 2014-08-31
关键词:
AddressAdultAffectAgeAgricultureAnthocyaninsAnti-Bacterial AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAnti-inflammatoryAntiviral AgentsBacteriaBerryBiological AssayBiological FactorsBiological MarkersBotanicalsBusinessesCardiovascular systemCharacteristicsChewing GumChronicClinicalClinical ResearchClinical TrialsCollaborationsComplexCountryDataDental CareDental EnamelDental HygieneDental PlaqueDevelopmentDiabetes MellitusDiseaseDouble-Blind MethodDrug Delivery SystemsDrug FormulationsEcologyEventExhibitsFarming environmentFreeze DryingFruitFusobacterium nucleatumGeneticGingivaGingivitisGoalsHealthHealthcareHigh PrevalenceHumanImmuneImmune responseImmunologyIn VitroIncidenceIndustryInfectionInflammationInflammation MediatorsInflammatoryInvestigational New Drug ApplicationLeadLesionLow Birth Weight InfantMaineMasticationMeasuresMedicalMethodsMicrobial BiofilmsMilitary PersonnelModelingMouth DiseasesOralOral MedicineOral cavityOral healthPatternPeriodontal DiseasesPeriodontic specialtyPeriodontitisPeriodontiumPharmaceutical PreparationsPharmacy (field)PhasePhytochemicalPopulationPorphyromonas gingivalisPowder dose formPredispositionPreventionPropertyProtocols documentationQuality ControlRandomizedReactive Oxygen SpeciesReportingResearchResearch PersonnelResourcesRiskRisk MarkerSalivaSeveritiesSimulateSmall Business Technology Transfer ResearchStreptococcus mutansSystemic diseaseTechnologyTestingTherapeuticTigersTissuesTooth LossTranslational ResearchUnderserved PopulationUnited Statesantimicrobialbactericidebaseclinical efficacycommercializationcompliance behaviorcostcost effectiveimprovedinnovationmeetingsmicrobialnovelpolyphenolpreventquality assurance

项目摘要

项目成果

CRAIG S MILLER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):牙周炎是一种多微生物疾病,在龈下沟生物膜中成熟的复杂微生物生态引发慢性免疫炎性病变,破坏牙周组织的软硬组织。尽管近年来口腔健康状况有了很大改善,但牙龈炎和牙周病仍然很突出,影响了美国30岁以上成年人的一半左右,在服务不足、发展中国家和不发达国家的患病率甚至更高。识别治疗方法的能力,使更有效地控制和/或预防牙龈炎症,是当前改善人口口腔健康的商业战略的一个关键方面。为了满足对安全,具有成本效益的抗牙龈炎产品/技术的未满足需求,促进患者的高依从性,并可纳入日常使用,我们开发了一种新型,直接压缩口香糖配方,含有冻干黑莓粉(FBP),具有抗炎,抗菌和抗病毒作用。我们的初步研究结果表明,这种口香糖产品在商业上是可行的,对预防和/或治疗牙龈炎可能有效。该II期STTR提案的目标是生产含有FBP的口香糖,该口香糖可将生物活性植物化学物质输送到口腔,并测试其在预防人类生物膜形成和牙龈炎方面的功效。研究将
英文摘要
DESCRIPTION (provided by applicant): Periodontitis represents a polymicrobial disease, in which a complex microbial ecology that matures in biofilms in the subgingival sulcus triggers a chronic immune-inflammatory lesion that destroys soft and hard tissues of the periodontium. Despite the great improvement in oral health in recent years, gingivitis and periodontal disease remain prominent and affect about half of all adults above the age of 30 years in the U.S., with an even higher prevalence in the underserved and developing and undeveloped countries. The ability to identify therapeutics, to enable more effective control and/or prevention of gingival inflammation, is a critical facet of current commercial strategies to improve oral health of the population. To address the unmet need for safe, cost-effective anti-gingivitis product/technology that promotes high patient compliance and could be incorporated into daily use, we have developed a novel, direct compression chewing gum formulation that contains freeze-dried blackberry powder (FBP) which is anti-inflammatory, antibacterial and antiviral. Our preliminary findings suggested this gum product is commercially viable and potentially effective for the prevention and/or treatment of gingivitis. The goal of this Phase II STTR proposal is to manufacture the chewing gum containing FBP that delivers bioactive phytochemicals to the oral cavity and test its efficacy in preventing biofilm formation and gingivitis in humans. Studies will determine the final gum product specifications and manufacturing method. A cGMP batch will be manufactured and Quality Control testing and Quality Assurance release will be performed. Submission and approval of an Investigational New Drug Application (IND) for an initial clinical study will be pursued based on guidance from our pre-IND meeting with FDA. In a randomized, double-blind, single center clinical efficacy study, we will assess the chewing gum's ability to reduce i) levels of several plaque-forming bacteria species on enamel and in saliva using the retrievable enamel chip model, and ii) clinical gingival inflammation, oral microbial burden and saliva biomarkers of inflammation in humans. These studies, if successful, will lead to a subsequent IND submission to complete multi-center trials and eventual NDA submission of the product for registration as a "Botanical Drug Product" as addressed under the FDA Guidance Document of the same title. Four Tigers LLC has partnered with WindStone Farms, the largest blackberry farm in the eastern part of the United States, to develop and commercialize health and medical products derived from blackberries. The investigators have assembled a highly interdisciplinary team encompassing collaborations between the agriculture industry, oral biologists, small business, and Tom's of Maine, a large healthcare company that focuses on all-natural products, that together will lead to the manufacture and commercial availability of an innovative blackberry chewing gum that releases and delivers natural bioactive substances from freeze-dried fruit powder that will help prevent/treat gingivitis. PUBLIC HEALTH RELEVANCE: This project presents the unique collaboration between the agriculture industry, oral biologists, small business, and a large healthcare company that will lead to the manufacture and commercial availability of an innovative blackberry chewing gum that releases and delivers natural bioactive substances from freeze-dried fruit powder that will help prevent/treat gingivitis. Use of this novel adjunctive oral hygiene aid could greatly reduce the cost of dental care by preventing oral disease before it occurs, and can be used by those who lack access to conventional oral hygiene measures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delivery of Polyphenols in Gum for Treatment of Gingivitis
  • 批准号:
    7664694
  • 项目类别:
  • 资助金额:
    $10.07万
  • 财政年份:
    2009
  • 负责人:
    CRAIG S MILLER
  • 依托单位:
Delivery of Polyphenols in Gum for Treatment of Gingivitis
  • 批准号:
    8538937
  • 项目类别:
  • 资助金额:
    $31.36万
  • 财政年份:
    2009
  • 负责人:
    CRAIG S MILLER
  • 依托单位:
Effects of ART on Oral Epithelial Cell Biology
  • 批准号:
    7478816
  • 项目类别:
  • 资助金额:
    $18.11万
  • 财政年份:
    2007
  • 负责人:
    CRAIG S MILLER
  • 依托单位:
Effects of ART on Oral Epithelial Cell Biology
  • 批准号:
    7276493
  • 项目类别:
  • 资助金额:
    $21.98万
  • 财政年份:
    2007
  • 负责人:
    CRAIG S MILLER
  • 依托单位:
海外基金